Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cataplexy”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Large-scale testing (Phase 3)Study completedNCT05059223
What this trial is testing

Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 90
Large-scale testing (Phase 3)Study completedNCT05113745
What this trial is testing

Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

Who this might be right for
NarcolepsyCataplexyExcessive Daytime Sleepiness
Axsome Therapeutics, Inc. 68
Testing effectiveness (Phase 2)Study completedNCT04072380
What this trial is testing

Evaluate Safety, and Efficacy of SUVN-G3031 (Samelisant) in Patients With Narcolepsy With and Without Cataplexy

Who this might be right for
Narcolepsy
Suven Life Sciences Limited 190
Not applicableStudy completedNCT01394614
What this trial is testing

Risk of Narcolepsy Associated With Administration of H1N1 Vaccine

Who this might be right for
Narcolepsy
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal 24
Testing effectiveness (Phase 2)Study completedNCT01183312
What this trial is testing

Flumazenil for the Treatment of Primary Hypersomnia

Who this might be right for
HypersomniaPrimary HypersomniaIdiopathic Hypersomnia+1 more
Lynn Marie Trotti 10
Testing effectiveness (Phase 2)Ended earlyNCT04096560
What this trial is testing

TAK-994 in Adults With Type 1 and Type 2 Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT1)Narcolepsy Type 2 (NT2)
Takeda 97
Large-scale testing (Phase 3)Study completedNCT02221869
What this trial is testing

Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy

Who this might be right for
Narcolepsy With Cataplexy
Jazz Pharmaceuticals 106
Not applicableNo Longer AvailableNCT03433131
What this trial is testing

Expanded Access Program to Provide Treatment With Pitolisant to Adult Patients in the U.S. With Excessive Daytime Sleepiness Associated With Narcolepsy With or Without Cataplexy

Who this might be right for
Narcolepsy Without CataplexyNarcolepsy With Cataplexy
Harmony Biosciences Management, Inc.
Testing effectiveness (Phase 2)Study completedNCT05687916
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 2

Who this might be right for
Narcolepsy Type 2
Takeda 71
Not applicableStudy completedNCT05314556
What this trial is testing

Group Psychotherapy in Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Cantonal Hospital of St. Gallen 10
Large-scale testing (Phase 3)Study completedNCT01399606
What this trial is testing

Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)

Who this might be right for
NarcolepsyCataplexy
Bioprojet 102
Testing effectiveness (Phase 2)Study completedNCT03881852
What this trial is testing

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

Who this might be right for
NarcolepsyCataplexy NarcolepsyExcessive Sleepiness
Axsome Therapeutics, Inc. 21
Large-scale testing (Phase 3)Study completedNCT06470828
What this trial is testing

TAK-861 for the Treatment of Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 168
Testing effectiveness (Phase 2)Ended earlyNCT04820842
What this trial is testing

TAK-994 in Adults With Narcolepsy

Who this might be right for
Narcolepsy Type 1 (NT 1)
Takeda 26
Large-scale testing (Phase 3)Not Yet RecruitingNCT07455383
What this trial is testing

Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 150
Early research (Phase 1)Study completedNCT01093508
What this trial is testing

Single-dose Safety Study of APD916 in Healthy Volunteers

Who this might be right for
Narcolepsy With or Without Cataplexy
Arena Pharmaceuticals 72
Not applicableNot Yet RecruitingNCT06383806
What this trial is testing

Decreasing Nightmares in Adults With Narcolepsy

Who this might be right for
NarcolepsyNarcolepsy Type 1Narcolepsy With Cataplexy+3 more
University of Utah 80
Testing effectiveness (Phase 2)Study completedNCT04026958
What this trial is testing

Clarithromycin Mechanisms in Hypersomnia Syndromes

Who this might be right for
Narcolepsy Without CataplexyIdiopathic HypersomniaNarcolepsy With Cataplexy
Emory University 83
Large-scale testing (Phase 3)Not Yet RecruitingNCT05914194
What this trial is testing

A Eight-Week Study of NLS-2 (Mazindol Extended Release) in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1Narcolepsy With Cataplexy
NLS Pharmaceutics 48
Testing effectiveness (Phase 2)Study completedNCT05687903
What this trial is testing

TAK-861 in Participants With Narcolepsy Type 1

Who this might be right for
Narcolepsy Type 1
Takeda 112
Load More Results